Terms: = Thyroid cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Staging
4 results:
1. Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer.
Semsar-Kazerooni K; Morand GB; Payne AE; da Silva SD; Forest VI; Hier MP; Pusztaszeri MP; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2022 Mar; 51(1):9. PubMed ID: 35246262
[TBL] [Abstract] [Full Text] [Related]
2. Associations between clinical characteristics and oncogene expression in patients with non-small cell lung cancer.
Han Y; Yu DP; Zhou SJ; Song XY; Li YS; Xiao N; Liu ZD; Sun XJ; Zhao QY; Liu SK
Genet Mol Res; 2014 Oct; 13(4):8913-24. PubMed ID: 25366782
[TBL] [Abstract] [Full Text] [Related]
3. Learning curve for endobronchial ultrasound‑guided transbronchial needle aspiration: experience of a community‑based teaching hospital.
Wang H; D'Cruz C; Yam DC; Dilla LM; Tsang P
Mol Med Rep; 2014 Nov; 10(5):2441-6. PubMed ID: 25189939
[TBL] [Abstract] [Full Text] [Related]
4. Primary oncocytic adenocarcinomas of the lung: a clinicopathologic, immunohistochemical, and molecular biologic analysis of 16 cases.
Solis LM; Raso MG; Kalhor N; Behrens C; Wistuba II; Moran CA
Am J Clin Pathol; 2010 Jan; 133(1):133-40. PubMed ID: 20023269
[TBL] [Abstract] [Full Text] [Related]
